lifetech scientific corp. - LFTSF

LFTSF

Close Chg Chg %
0.19 0.04 22.89%

Open Market

0.23

+0.04 (22.89%)

Volume: 100.00

Last Updated:

Feb 8, 2024, 10:34 AM EDT

Company Overview: lifetech scientific corp. - LFTSF

LFTSF Key Data

Open

$0.23

Day Range

0.23 - 0.23

52 Week Range

N/A - N/A

Market Cap

$835.94M

Shares Outstanding

4.40B

Public Float

3.69B

Beta

0.53

Rev. Per Employee

N/A

P/E Ratio

24.96

EPS

-$0.00

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

913.64

 

LFTSF Performance

No Data Available

LFTSF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About lifetech scientific corp. - LFTSF

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. It operates its business through the following segments: Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business. The Structural Heart Diseases Business segment offers trade, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is involved with the trade, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment focuses on trade, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The company was founded in 1999 and is headquartered in Shenzhen, China.

LFTSF At a Glance

LifeTech Scientific Corp.
LifeTech Scientific Building
Shenzhen, Guangdong 518057
Phone 86-755-8602-6250 Revenue 178.85M
Industry Medical Specialties Net Income 37.15M
Sector Health Technology 2023 Sales Growth 9.754%
Fiscal Year-end 12 / 2024 Employees 1,446
View SEC Filings

LFTSF Valuation

P/E Current 24.955
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 35.406
Price to Sales Ratio 7.481
Price to Book Ratio 2.786
Price to Cash Flow Ratio 22.005
Enterprise Value to EBITDA 23.446
Enterprise Value to Sales 6.523
Total Debt to Enterprise Value 0.001

LFTSF Efficiency

Revenue/Employee 123,687.752
Income Per Employee 25,694.802
Receivables Turnover 2.521
Total Asset Turnover 0.30

LFTSF Liquidity

Current Ratio 2.897
Quick Ratio 2.269
Cash Ratio 1.531

LFTSF Profitability

Gross Margin 77.539
Operating Margin 22.41
Pretax Margin 14.011
Net Margin 20.774
Return on Assets 6.229
Return on Equity 8.327
Return on Total Capital 7.797
Return on Invested Capital 8.316

LFTSF Capital Structure

Total Debt to Total Equity 0.276
Total Debt to Total Capital 0.275
Total Debt to Total Assets 0.198
Long-Term Debt to Equity 0.089
Long-Term Debt to Total Capital 0.089
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lifetech Scientific Corp. - LFTSF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
93.06M 143.48M 162.96M 178.85M
Sales Growth
-3.87% +54.18% +13.58% +9.75%
Cost of Goods Sold (COGS) incl D&A
19.61M 28.88M 35.02M 40.17M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
8.25M 8.73M 8.93M 9.68M
Depreciation
7.24M 7.28M 7.02M 7.71M
Amortization of Intangibles
1.01M 1.45M 1.91M 1.97M
COGS Growth
-3.37% +47.26% +21.23% +14.73%
Gross Income
73.44M 114.59M 127.94M 138.68M
Gross Income Growth
-4.00% +56.03% +11.65% +8.39%
Gross Profit Margin
+78.92% +79.87% +78.51% +77.54%
2020 2021 2022 2023 5-year trend
SG&A Expense
70.90M 65.13M 81.04M 98.60M
Research & Development
23.40M 21.41M 29.25M 40.43M
Other SG&A
47.49M 43.73M 51.78M 58.17M
SGA Growth
+16.07% -8.13% +24.42% +21.67%
Other Operating Expense
- - - -
-
Unusual Expense
(28.99M) 11.51M 10.30M 25.73M
EBIT after Unusual Expense
31.53M 37.95M 36.60M 14.35M
Non Operating Income/Expense
7.75M 14.21M 19.90M 10.81M
Non-Operating Interest Income
963.31K 1.19M 2.47M 1.80M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.72M 404.54K 93.86K 101.91K
Interest Expense Growth
+27.22% -89.13% -76.80% +8.58%
Gross Interest Expense
3.72M 404.54K 93.86K 101.91K
Interest Capitalized
- - - -
-
Pretax Income
35.56M 51.76M 56.40M 25.06M
Pretax Income Growth
+43.80% +45.55% +8.98% -55.57%
Pretax Margin
+38.21% +36.07% +34.61% +14.01%
Income Tax
5.15M 7.69M 8.81M 9.61M
Income Tax - Current - Domestic
5.68M 9.41M 11.12M 12.49M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(520.99K) (1.72M) (2.32M) (2.88M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
30.00M 43.94M 47.33M 15.17M
Minority Interest Expense
(1.31M) (1.41M) (979.85K) (21.98M)
Net Income
31.31M 45.35M 48.31M 37.15M
Net Income Growth
+67.43% +44.85% +6.54% -23.10%
Net Margin Growth
+33.64% +31.61% +29.65% +20.77%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
31.31M 45.35M 48.31M 37.15M
Preferred Dividends
- - - -
-
Net Income Available to Common
31.31M 45.35M 48.31M 37.15M
EPS (Basic)
0.0072 0.0105 0.0114 0.0085
EPS (Basic) Growth
+60.00% +45.83% +8.57% -25.44%
Basic Shares Outstanding
4.34B 4.31B 4.23B 4.36B
EPS (Diluted)
0.0071 0.0099 0.011 0.0084
EPS (Diluted) Growth
+57.78% +39.44% +11.11% -23.64%
Diluted Shares Outstanding
4.39B 4.56B 4.41B 4.45B
EBITDA
10.80M 58.19M 55.84M 49.76M
EBITDA Growth
-52.23% +438.75% -4.05% -10.89%
EBITDA Margin
+11.61% +40.56% +34.26% +27.82%

Lifetech Scientific Corp. in the News